# Medicines and Medical Devices Act 2021, Section 14: Interpretation of Part 3 and supplementary provision


(1) In this Part—
“active substance” means any substance or mixture of substances intended to be used in the manufacture of a veterinary medicine that, when used in its production, becomes an active ingredient of that medicine;
“appropriate authority” has the meaning given by section 10(6);
“manufacture” includes assembly;
“marketing authorisation” means an authorisation to market a veterinary medicine in the United Kingdom;
“veterinary medicine” means a veterinary medicinal product within the meaning given by regulation 2 of the Veterinary Medicines Regulations 2013 (S.I. 2013/2033).
(2) In the Animals (Scientific Procedures) Act 1986, in section 2 (regulated procedures), in subsection (8)(d), after “the Veterinary Medicines Regulations 2011” insert “ or the Veterinary Medicines Regulations 2013 ”.

---
Source: https://www.legislation.gov.uk/ukpga/2021/3/section/14 (the official version)
Page: https://openlegislation.uk/medicines-and-medical-devices-act-2021/section-14
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.